Report Update Apr 15, 2024

Hong Kong SAR, China - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Hong Kong SAR, China: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Hong Kong SAR, China

The Hong Kong medicaments containing insulin market was finally on the rise to reach $X in 2023, after two years of decline. Overall, consumption, however, showed a perceptible curtailment. As a result, consumption attained the peak level of $X. From 2021 to 2023, the growth of the market failed to regain momentum.

Medicaments Containing Insulin Production in Hong Kong SAR, China

In value terms, medicaments containing insulin production amounted to $X in 2023 estimated in export price. In general, production saw a buoyant increase. The most prominent rate of growth was recorded in 2019 when the production volume increased by X%. Medicaments containing insulin production peaked at $X in 2021; however, from 2022 to 2023, production failed to regain momentum.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Medicaments Containing Insulin Exports

Exports from Hong Kong SAR, China

After two years of growth, overseas shipments of medicaments containing insulin but not antibiotics decreased by X% to X tons in 2023. In general, exports, however, posted a significant increase. The most prominent rate of growth was recorded in 2019 with an increase of X% against the previous year. As a result, the exports reached the peak of X tons. From 2020 to 2023, the growth of the exports remained at a lower figure.

In value terms, medicaments containing insulin exports reduced to $X in 2023. Overall, exports, however, saw a significant expansion. The pace of growth appeared the most rapid in 2019 with an increase of X%. As a result, the exports attained the peak of $X. From 2020 to 2023, the growth of the exports failed to regain momentum.

Exports by Country

Denmark (X tons) was the main destination for medicaments containing insulin exports from Hong Kong SAR, with a approx. X% share of total exports.

From 2012 to 2023, the average annual growth rate of volume to Denmark totaled X%.

In value terms, Denmark ($X) also remains the key foreign market for medicaments containing insulin but not antibiotics exports from Hong Kong SAR.

From 2012 to 2023, the average annual rate of growth in terms of value to Denmark stood at X%.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2023, therefore, remained relatively stable against the previous year. Overall, the export price recorded a remarkable increase. The growth pace was the most rapid in 2019 an increase of X%. Over the period under review, the average export prices hit record highs at $X per ton in 2021; afterwards, it flattened through to 2023.

As there is only one major export destination, the average price level is determined by prices for Denmark.

From 2012 to 2023, the rate of growth in terms of prices for Denmark amounted to X% per year.

Medicaments Containing Insulin Imports

Imports into Hong Kong SAR, China

In 2023, supplies from abroad of medicaments containing insulin but not antibiotics decreased by X% to X kg for the first time since 2019, thus ending a three-year rising trend. Over the period under review, imports recorded a noticeable slump. The most prominent rate of growth was recorded in 2015 with an increase of X% against the previous year. As a result, imports attained the peak of X kg. From 2016 to 2023, the growth of imports remained at a lower figure.

In value terms, medicaments containing insulin imports dropped markedly to $X in 2023. In general, imports recorded a relatively flat trend pattern. The growth pace was the most rapid in 2015 when imports increased by X% against the previous year. As a result, imports attained the peak of $X. From 2016 to 2023, the growth of imports remained at a somewhat lower figure.

Imports by Country

In 2023, the UK (X kg) constituted the largest supplier of medicaments containing insulin to Hong Kong SAR, accounting for a X% share of total imports. Moreover, medicaments containing insulin imports from the UK exceeded the figures recorded by the second-largest supplier, the United States (X kg), fourfold.

From 2012 to 2023, the average annual rate of growth in terms of volume from the UK totaled X%.

In value terms, the UK ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Hong Kong SAR, comprising X% of total imports. The second position in the ranking was held by the United States ($X), with a X% share of total imports.

From 2012 to 2023, the average annual rate of growth in terms of value from the UK stood at X%.

Import Prices by Country

In 2023, the average medicaments containing insulin import price amounted to $X per ton, declining by X% against the previous year. In general, the import price, however, showed a perceptible expansion. The pace of growth appeared the most rapid in 2019 an increase of X% against the previous year. The import price peaked at $X per ton in 2021; however, from 2022 to 2023, import prices remained at a lower figure.

Average prices varied somewhat amongst the major supplying countries. In 2023, amid the top importers, the country with the highest price was the United States ($X per ton), while the price for the UK amounted to $X per ton.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by the UK (X%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

This report provides an in-depth analysis of the medicaments containing insulin market in Hong Kong SAR, China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Hong Kong SAR

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in Hong Kong SAR, China
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023